Corticotropin Releasing Hormone and its Function in the Skin

Abstract

The skin, as the largest organ of the body, is strategically located as a barrier between the external and internal environments, being permanently exposed to noxious stressors such as bursts of radiation (solar, thermal), mechanical energy, or chemical and biological insults. Because of its functional domains and structural diversity, the skin must have a constitutive mechanism for dealing with the stressors. Activities of the skin are mostly regulated by local cutaneous factors and stressed skin can generate signals to produce rapid (neural) or slow (humoral) responses to local or systemic levels. Thus, the skin neuroendocrine system is comprised of locally produced neuroendocrine mediators that interact with corresponding specific receptors through para- or autocrine mechanisms. Furthermore, it is known for several years that the corticotropin-releasing hormone (CRH)/ pro-opiomelanocorticotropin (POMC) skin system fulfils analogous functions to the hypothalamic-pituitary-adrenal (HPA) stress axis. Additionally, skin cells produce hormones, neurotansmitters and neuropeptides, having the corresponding receptors and the skin itself is able to fulfill a multidirectional communication between endocrine, immune and central nervous systems as well as other internal organs. In summary, the skin expresses an equivalent of the prominent hypothalamic-pituitary-adrenal stress axis that may act as a cutaneous defense system, operating as a coordinator and executor of local responses to stress, in addition to its normal function: the preservation of body homeostasis.

Keywords

cutaneous HPA axis - CRH - skin

References

• 1 Slominski A, Mihm MC. Potential mechanism of skin response to stress.  Int J Dermatol. 1996;  35 849-851
• 2 Slominski A, Wortsman J. Neuroendocrinology of the skin.  Endocr Rev. 2000;  21 457-487
• 3 Slominski A. Neuroendocrine system of the skin.  Dermatology. 2005;  211 199-208
• 4 Slominski A, Szczesniewski A, Wortsman J. Liquid chromatography-mass spectrometry detection of corticotropin-releasing hormone and proopiomelanocortin-derived peptides in human skin.  J Clin Endocrinol Metab. 2000;  85 3582-3588
• 5 Slominski A, Wortsman J, Luger T, Paus R, Solomon S. Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress.  Physiol Rev. 2000;  80 979-1020
• 6 Slominski AT, Roloff B, Zbytek B, Wei ET, Fechner K, Curry J, Wortsman J. Corticotropin releasing hormone and related peptides can act as bioregulatory factors in human keratinocytes.  In Vitro Cell Dev Biol Anim. 2000;  36 211-216
• 7 Zouboulis CC. Human skin: an independent peripheral endocrine organ.  Horm Res. 2000;  54 230-242
• 8 Slominski A, Ermak G, Mihm MC. ACTH receptor, CYP11A1, CYP17 and CYP21A2 genes are expressed in skin.  J Clin Endocrinol Metab. 1996;  7 2746-2749
• 9 Slominski A, Zbytek B, Szczesniewski A, Semak I, Kaminski J, Sweatman T, Wortsman J. CRH stimulation of corticosteroids production in melanocytes is mediated by ACTH.  Am J Physiol Endocrinol Metab. 2005;  288 E701-E706 , [Epub 2004 Nov 30. Erratum in: Am J Physiol Endocrinol Metab. 2006; 290: E204]
• 10 Chrousos GP. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation.  N Engl J Med. 1995;  332 1351-1362
• 11 Grammatopoulos DK, Chrousos GP. Functional characteristics of CRH receptors and potential clinical applications of CRH-receptor antagonists.  Trends Endocrinol Metab. 2002;  13 436-444
• 12 Smith AI, Funder JW. Proopiomelanocortin processing in the pituitary, central nervous system, and peripheral tissues.  Endocr Rev. 1988;  9 159-179
• 13 Shibahara S, Morimoto Y, Furutani Y, Notake M, Takahashi H, Shimizu S, Horikawa S, Numa S. Isolation and sequence analysis of the human corticotropin-releasing factor precursor gene.  Embo J. 1983;  2 775-779
• 14 Thompson RC, Seasholtz AF, Herbert E. Rat corticotropin-releasing hormone gene: sequence and tissue-specific expression.  Mol Endocrinol. 1987;  1 363-370
• 15 Orth DN. Corticotropin-releasing hormone in humans.  Endocr Rev. 1992;  13 164-191
• 16 Stephanou A, Jessop DS, Knight RA, Lightman SL. Corticotrophin-releasing factor-like immunoreactivity and mRNA in human leukocytes.  Brain Behav Immun. 1990;  4 67-73
• 17 Jones KL. The Cushing syndromes.  Pediatr Clin North Am. 1990;  37 1313-1332
• 18 Sarnyai Z, Shaham Y, Heinrichs SC. The role of corticotropin-releasing factor in drug addiction.  Pharmacol Rev. 2001;  53 209-243
• 19 Heinrichs SC, De Souza EB. Corticotropin-releasing factor antagonists, binding-protein and receptors: implications for central nervous system disorders.  Baillieres Best Pract Res Clin Endocrinol Metab. 1999;  13 541-554
• 20 Chrousos GP. The role of stress and the hypothalamic-pituitary-adrenal axis in the pathogenesis of the metabolic syndrome: neuro-endocrine and target tissue-related causes.  Int J Obes Relat Metab Disord. 2000;  24 ((Suppl 2)) S50-S55
• 21 Gold PW, Chrousos GP. Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states.  Mol Psychiatry. 2002;  7 254-275
• 22 Wahle M, Krause A, Pierer M, Hantzschel H, Baerwald CG. Immunopathogenesis of rheumatic diseases in the context of neuroendocrine interactions.  Ann N Y Acad Sci. 2002;  966 355-364
• 23 Hiroi N, Wong ML, Licinio J, Park C, Young M, Gold PW, Chrousos GP, Bornstein SR. Expression of corticotropin releasing hormone receptors type I and type II mRNA in suicide victims and controls.  Mol Psychiatry. 2001;  6 540-546
• 24 Zouboulis CC, Seltmann H, Hiroi N, Chen W, Young M, Oeff M, Scherbaum WA, Orfanos CE, McCann SM, Bornstein SR. Corticotropin-releasing hormone: an autocrine hormone that promotes lipogenesis in human sebocytes.  Proc Natl Acad Sci USA. 2002;  99 7148-7153
• 25 Krause K, Schnitger A, Fimmel S, lass E, Zouboulis CC. Corticotropin-releasing hormone skin signalling is receptor-mediated and is predominant in the sebaceous glands.  Horm Metab Res. , in press
• 26 Slominski A, Zbytek B, Pisarchik A, Slominski RM, Zmijewski M A, Wortsman J. CRH functions as a growth factor/cytokine in the skin.  J Cell Physiol. 2006;  206 780-791
• 27 Zbytek B, Pikula M, Slominski RM, Mysliwski A, Wei E, Wortsman J, Slominski AT. Corticotropin-releasing hormone triggers differentiation in HaCaT keratinocytes.  Br J Dermatol. 2005;  152 474-480
• 28 Quevedo ME, Slominski A, Pinto W, Wei E, Wortsman J. Pleiotropic effects of corticotropin releasing hormone on normal human skin keratinocytes.  In Vitro Cell Dev Biol Anim. 2001;  37 50-54
• 29 Slominski A, Wortsman J, Pisarchik A, Zbytek B, Linton EA, Mazurkiewicz JE, Wei ET. Cutaneous expression of corticotropin-releasing hormone (CRH), urocortin, and CRH receptors.  FASEB J. 2001;  10 1678-1693
• 30 Willenberg HS, Haase M, Papewalis C, Schott M, Scherbaum WA, Bornstein SR. Corticotropin-releasing hormone receptor expression on normal and tumorous human adrenocortical cells.  Neuroendocrinology. 2005;  82 ((5-6)) 274-281
• 31 Seres J, Bornstein SR, Seres P, Willenberg HS, Schulte KM, Scherbaum WA, Ehrhart-Bornstein M. Corticotropin-releasing hormone system in human adipose tissue.  J Clin Endocrinol Metab. 2004 Feb;  89 ((2)) 965-970
• 32 Ganceviciene R, Graziene V, Fimmel S, Zouboulis CC. Involvement of the Corticotropin-releasing hormone system in the pathogenesis of acne vulgaris.  , Submitted for publication
• 33 Slominski A, Pisarchik A, Tobin DJ, Mazurkiewicz JE, Wortsman J. Differential expression of a cutaneous corticotropin-releasing hormone system.  Endocrinology. 2004;  145 941-950
• 34 Zbytek B, Pfeffer LM, Slominski AT. Corticotropin-releasing hormone stimulates NF-kappaB in human epidermal keratinocytes.  J Endocrinol. 2004;  181 R1-R7
• 35 Papadopoulou N, Kalogeromitros D, Staurianeas NG, Tiblalexi D, Theoharides TC. Corticotropin-releasing hormone receptor-1 and histidine decarboxylase expression in chronic urticaria.  J Invest Dermatol. 2005;  125 952-955
• 36 Bienenstock J, Tomioka M, Matsuda H, Stead RH, Quinonez G, Simon GT, Coughlin, MD, Denburg JA. The role of mast cells in inflammatory processes: evidence for nerve/mast cell interactions.  Int Arch Allergy Appl Immunol. 1987;  82 238-243
• 37 Maurer M, Theoharides T, Granstein RD, Bischoff SC, Bienenstock J, Henz B, Kovanen P, Piliponsky AM, Kambe N, Vliagoftis H, Levi-Schaffer F, Metz M, Miyachi Y, Befus D, Forsythe P, Kitamura Y, Galli S. What is the physiological function of mast cells?.  Exp Dermatol. 2003;  12 886-910
• 38 Ito N, Ito T, Kromminga A, Bettermann A, Takigawa M, Kees F, Straub RH, Paus R. Human hair follicles display a functional equivalent of the hypothalamic-pituitary-adrenal axis and synthesize cortisol.  FASEB J. 2005;  19 1332-1334
• 39 Itoi K, Seasholtz AF, Watson SJ. Cellular and extracellular regulatory mechanisms of hypothalamic corticotropin-releasing hormone neurons.  Endocr J. 1998;  45 13-33
• 40 Böhm M, Schiller M, Ständer S, Seltmann H, Li Z, Brzoska T, Metze D, Schiöth HB, Skottner A, Seiffert K, Zouboulis CC, Luger TA. Evidence for expression of melanocortin-1 receptor in human sebocytes in vitro and in situ. Evidence for expression of melanocortin-1 receptor in human sebocytes in vitro and in situ.  J Invest Dermatol. 2002;  118 533-539
• 41 Kane MO, Murphy EP, Kirby B. The role of corticotropin-releasing hormone in immune-mediated cutaneous inflammatory disease.  Exp Dermatol. 2006;  15 143-153
• 42 Biro T, Ko MC, Bromm B, Wei ET, Bigliardi P, Siebenhaar F, Hashizume H, Misery L, Bergasa NV, Kamei C, Schouenborg J, Roostermann D, Szabo T, Maurer M, Bigliardi-Qi M, Meingassner JG, Hossen MA, Schmelz M, Steinhoff M. How best to fight that nasty itch - from new insights into the neuroimmunological, neuroendocrine, and neurophysiological bases of pruritus to novel therapeutic approaches.  Exp Dermatol. 2005;  14 225-240
• 43 Theoharides TC, Donelan JM, Papadopoulou N, Cao J, Kempuraj D, Conti P. Mast cells as targets of corticotropin-releasing factor and related peptides.  Trends Pharmacol Sci. 2004;  25 563-568

Correspondence